Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
EQ | Equillium, Inc. | Chief Financial Officer | $107K | -$16.8K | -13.6% | Sep 26, 2024 |
CARM | Carisma Therapeutics Inc. | Director | $23.5K | Jun 22, 2022 | ||
ACTU | ACTUATE THERAPEUTICS, INC. | Director | Aug 12, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|